跳轉至內容
Merck
全部照片(1)

Key Documents

D0400000

醋酸去氧皮质酮

European Pharmacopoeia (EP) Reference Standard

同義詞:

11-去氧皮质酮乙酸酯, 21-乙酰氧基孕甾-4-烯-3,20-二酮, 21-羟基孕甾-4-烯-3,20-二酮-21-醋酸酯, 21-羟基孕酮-21-乙酸酯, DOC 乙酸酯, 乙酸脱氧肾上腺皮质固酮, 孕甾-4-烯-21-醇-3,20-二酮-21-醋酸酯, 脱氧皮质酮醋酸酯

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C23H32O4
CAS號碼:
分子量::
372.50
Beilstein:
2570798
MDL號碼:
分類程式碼代碼:
41116107
PubChem物質ID:
NACRES:
NA.24

等級

pharmaceutical primary standard

API 家族

desoxycortone

製造商/商標名

EDQM

應用

pharmaceutical (small molecule)

格式

neat

SMILES 字串

[H][C@@]12CCC3=CC(=O)CC[C@]3(C)[C@@]1([H])CC[C@]4(C)[C@]([H])(CC[C@@]24[H])C(=O)COC(C)=O

InChI

1S/C23H32O4/c1-14(24)27-13-21(26)20-7-6-18-17-5-4-15-12-16(25)8-10-22(15,2)19(17)9-11-23(18,20)3/h12,17-20H,4-11,13H2,1-3H3/t17-,18-,19-,20+,22-,23-/m0/s1

InChI 密鑰

VPGRYOFKCNULNK-ACXQXYJUSA-N

基因資訊

human ... NR3C2(4306)

尋找類似的產品? 前往 產品比較指南

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

應用

Desoxycortone acetate EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

包裝

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

其他說明

Sales restrictions may apply.

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

抱歉,我們目前沒有在線上提供本產品的COA

如果您需要協助,請聯絡 客戶支援

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

D Villarreal et al.
The American journal of physiology, 264(4 Pt 2), H1187-H1193 (1993-04-01)
The acute and chronic interactions of the renal nerves, atrial natriuretic factor (ANF), and mineralocorticoids for the regulation of sodium balance were examined in dogs with an arteriovenous (AV) fistula and the syndrome of high-output heart failure (HOHF) (n =
Joseph Fomusi Ndisang et al.
The Journal of pharmacology and experimental therapeutics, 334(1), 87-98 (2010-04-16)
We investigated the role of heme oxygenase (HO), adiponectin, and atrial natriuretic peptide (ANP) in uninephrectomized (UnX) deoxycorticosterone-acetate (DOCA)-salt hypertensive rats, a volume-overload model characterized by elevated endothelin-1 (ET-1), mineralocorticoid-induced oxidative/inflammatory insults, fibrosis, hypertrophy, and severe renal histopathological lesions that
Volker Vallon et al.
Journal of molecular medicine (Berlin, Germany), 84(5), 396-404 (2006-04-11)
The mineralocorticoids aldosterone and deoxycorticosterone acetate (DOCA) stimulate renal tubular salt reabsorption, increase salt appetite, induce extracellular volume expansion, and elevate blood pressure. Cardiac effects of mineralocorticoids include stimulation of matrix protein deposition leading to cardiac fibrosis, which is at
Cleci M Moreira et al.
Clinics (Sao Paulo, Brazil), 67(5), 489-496 (2012-06-06)
Tension cost, the ratio of myosin ATPase activity to tension, reflects the economy of tension development in the myocardium. To evaluate the mechanical advantage represented by the tension cost, we studied papillary muscle contractility and the activity of myosin ATPase
Michael J Morris et al.
Behavioral neuroscience, 124(2), 211-224 (2010-04-07)
Our laboratory has reported that manipulations that provoke a robust sodium appetite (e.g., sodium depletion, deoxycorticosterone acetate) decrease lateral hypothalamic self-stimulation (LHSS) reward if rats are denied access to hypertonic saline solutions. The following studies investigated the interaction between chronic

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務